OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 3.30.
Share Price | ₹98.3 | Jun 02,2025 |
Market Cap | ₹363.5 Cr | |
Sales-TTM | ₹110.0 Cr | TTM-Standalone Results |
Price/Sales | 3.30x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹363.5 Cr] as on Jun 02,2025
(/) Sales [ ₹110.0 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 3.30x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '3.30 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.94x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 2.45x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | 110.0 | 3.30 | 363.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.64 | 401,865.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.54 | 173,574.0 |
CIPLA LTD | 27,547.6 | 4.31 | 118,710.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.20 | 105,964.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.19 | 104,232.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.11 | 99,618.8 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.02 | 93,474.1 |
LUPIN LTD | 22,707.9 | 3.94 | 89,505.5 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.08 | 65,993.6 |
ABBOTT INDIA LTD | 6,409.2 | 10.17 | 65,158.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.08x |
Max industry PS | 18.54x |
Median industry PS | 4.31x |
Average industry PS | 6.77x |
You may also like the below Video Courses